KalVista Pharmaceuticals, Inc. (KALV)

$10.75 -3.08% $-0.34 Healthcare

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; KVD824, an oral product candidate for the treatment of HAE; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts.

$523.61M

Mr. Thomas Andrew Crockett M.B.A.

105.00

Cambridge, MA

Apr 09, 2015

-3.01

$-3.57

1.42

8.55

-11,755.47%

-3.62

-0.20

2.97

447.97

8.55

-70.82%

-97.37%

Similar stocks (15)

Cytokinetics, Incorporated

CYTK

$56.19 -4.15%
Downtrend

Crinetics Pharmaceuticals, Inc.

CRNX

$58.78 -2.05%
Uptrend

Edgewise Therapeutics, Inc.

EWTX

$35.20 -0.37%
Uptrend

Dyne Therapeutics, Inc.

DYN

$29.33 4.27%
Downtrend

Mirum Pharmaceuticals, Inc.

MIRM

$43.16 3.73%
Uptrend

Kura Oncology, Inc.

KURA

$19.20 9.37%
Downtrend

Cogent Biosciences, Inc.

COGT

$10.38 -0.19%
Neutral

Cullinan Oncology, Inc.

CGEM

$16.02 -7.24%
Downtrend

Replimune Group, Inc.

REPL

$12.14 -2.86%
Uptrend

Larimar Therapeutics, Inc.

LRMR

$9.10 -2.05%
Neutral

Mersana Therapeutics, Inc.

MRSN

$2.32 -8.30%
Downtrend

Nuvectis Pharma, Inc.

NVCT

$10.64 -1.60%
Neutral

Gossamer Bio, Inc.

GOSS

$0.85 -1.21%
Downtrend

Kronos Bio, Inc.

KRON

$0.90 3.78%
Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.27 2.19%
Downtrend

ETF Exposure (16)

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.39%

$28.74 -2.11%
Uptrend

iShares Micro-Cap ETF

IWC

0.09759%

$135.90 -1.91%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.046%

$23.77 -2.42%
Uptrend

Direxion Daily S&P Biotech Bull 3X Shares

LABU

0.0427584669%

$134.40 -6.91%
Uptrend

iShares Biotechnology ETF

IBB

0.03138%

$144.36 -2.27%
Uptrend

iShares Russell 2000 Growth ETF

IWO

0.02909%

$308.15 -1.74%
Uptrend

iShares Russell 2000 ETF

IWM

0.01441%

$237.36 -1.79%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.013713015795510769%

$62.76 -5.40%
Uptrend

Dimensional U.S. Small Cap ETF

DFAS

0.00881113%

$69.37 -1.28%
Uptrend

Dimensional US Sustainability Core 1 ETF

DFSU

0.00272461%

$39.05 -0.51%
Uptrend

ProShares Hedge Replication ETF

HDG

0.0023591030588969507%

$50.24 -0.58%
Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

0.0021260999999999997%

$35.93 -0.53%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

7.8e-4%

$131.55 -0.45%
Uptrend

Dimensional US Core Equity Market ETF

DFAU

6.7535e-4%

$41.57 -0.38%
Uptrend

iShares Russell 3000 ETF

IWV

4.6e-4%

$342.01 -0.45%
Uptrend

Dimensional U.S. Equity ETF

DFUS

4.4686e-4%

$65.17 -0.40%
Uptrend